\nOs vencedores de 2022 ser\u00e3o anunciados nua online cerim\u00f3nia de entrega dos pr\u00e9mios em Novembro.<\/p>\n
<\/p>\n
Prof Jae Sung Hwang<\/strong> Dr Alison Gray<\/strong> Center for Contemporary Sciences<\/strong> Center for a Humane Economy and Animal Wellness Action<\/strong> Dr Marize Campos Valadares<\/strong> The New Zealand Anti-Vivisection Society (NZAVS)<\/strong> Omica Research and Innovation Ltd Comp<\/strong> <\/p>\n Jytte Guteland MEP<\/strong> Tilly Metz MEP<\/strong> In-soon Nam<\/strong> <\/p>\n Phoenix Zones Initiative<\/strong> Carlota Saorsa<\/strong> Jessica Lohmann<\/strong> Humane Society International<\/strong> Beagle Rescue Network<\/strong> Dr Costanza Rovida and Jean Knight<\/strong> Animal Testing<\/strong> <\/p>\n ONG Te Protejo<\/strong> Altertox SRL<\/strong> Animal Rights VZW<\/strong> <\/p>\n Stichting Proefdiervrij<\/strong> Centre for Predictive Human Model Systems, Atal Incubation Centre-Centre for Cellular and Molecular Biology (AIC-CCMB))<\/strong> Animal Free Research UK<\/strong> LIALT Laboratorio de Investigaci\u00f3n Alternativa<\/strong> Animal Welfare Academy of the German Animal Welfare Federation<\/strong> EU Reference Laboratory for alternatives to animal testing (EURL ECVAM)<\/strong> The European Society of Toxicology In Vitro (ESTIV)<\/strong> \u00c4rzte gegen Tierversuche e.V.<\/strong> Prof.dr. Pamela Bejdi\u0107, University of Sarajevo-Veterinary Faculty<\/strong> <\/p>\n Dr Baeckkyoung Sung<\/strong> Dr Marie-Gabrielle Zurich<\/strong> Artificial Intelligence Innovation Lab<\/strong> Joint Project Team of TissUse, Cosmetics Europe Long Range Science Strategy (LRSS) programme and Beiersdorf, namely: Katrin Brandmair, Thi Phuong Tao, Silke Gerlach, Nicky Hewitt, Jochen K\u00fchnl and Ilka Maschmeyer<\/strong> Dr Daniel Andr\u00e9 Gon\u00e7alves Ferreira<\/strong> Dr Sejoong Kim<\/strong> The Acute Systemic Toxicity team within RTI International<\/strong> AlveoliX AG<\/strong> CN Bio Innovations<\/strong> Computational toxicology teams at Instem and Innovatune<\/strong> Micro-Tissue Engineering (MicroTE) Lab \/ Queensland University of Technology<\/strong> Dr.-Ing. habil. Joachim Wiest<\/strong> European Commission Joint Research Centre, Directorate F- Health, Consumers and Reference Materials<\/strong> OECD Chemical Safety Programme<\/strong> Dr. Zhongze Gu<\/strong> ReproTracker Team, Developmental Toxicology Department, Toxys B.V.<\/strong> EU-ToxRisk – mitotoxicity case study team<\/strong> <\/p>\n Dr Supratik Kar, Jackson State University<\/strong> Xuelian Jia, Rutgers-Camden, Center for Computational and Integrative Biology<\/strong> Prof. Dr. Francesca Grisoni, Eindhoven University of Technology<\/strong> Dr Andreia Verissimo Luis, THT Biomaterials GmbH<\/strong> Dr Chrysanthi-Maria Moysidou, University of Cambridge, Dept of Chemical Engineering and Biotechnology<\/strong> Artur Silva, Federal University of Goi\u00e1s<\/strong> Dr Sara Tirendi, University of Genoa<\/strong> Dr Carlo Alberto Paggi, University of Twente<\/strong> Farzaneh Fayazbakhsh, Tehran University of Medical Sciences<\/strong> Dr Stefanie Klima, University of Konstanz<\/strong> Dr Stephen Evans, Swansea University<\/strong> Dr Sebastian Eggert, cellasys GmbH<\/strong> Thi Phuong Tao, TissUse GmbH<\/strong> Dr Pouria Fattahi, University of Pennsylvania<\/strong> Dr Arunima Sengupta, ARTORG Center, University of Bern<\/strong> Dr Arthur de Carvalho e Silva, University of Birmingham<\/strong> Dr Sudeep Joshi, The Francis Crick Institute and King’s College London<\/strong> Dr Shagun Krishna, National Toxicology Program (DNTP), National Institute of Environmental Health Services (NIEHS)<\/strong> Dr Paul Holloway, University of Oxford<\/strong> <\/p>\n","protected":false},"excerpt":{"rendered":" Os vencedores de 2022 ser\u00e3o anunciados nua online cerim\u00f3nia de entrega dos pr\u00e9mios em Novembro. Os pr\u00e9-seleccionados para o Pr\u00e9mio Lush 2022 s\u00e3o: Lobbying Prof Jae Sung Hwang South Korea National Center for Cosmetic R&D – Development of an animal alternative efficacy test method Dr Alison Gray UK Policy intervention to replace animal […]<\/p>\n","protected":false},"author":88892,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-32188","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n
\nSouth Korea
\nNational Center for Cosmetic R&D – Development of an animal alternative efficacy test method<\/p>\n
\nUK
\nPolicy intervention to replace animal derived antibodies with animal friendly affinity reagents<\/p>\n
\nUSA
\nCCS Lobbying to End Animal Testing<\/p>\n
\nUSA
\nThe FDA Modernization Act of 2021<\/p>\n
\nBrazil
\nLobbying for the best science available and building confidence in New Approach Methodologies in safety science<\/p>\n
\nAotearoa\/New Zealand
\nRemoval the social license of the Forced Swim Test in NZ<\/p>\n
\nTurkiye\/Turkey
\nOmic-A Skin<\/p>\n
\nRealiza\u00e7\u00e3o Pol\u00edtica<\/h2>\n
\nSweden<\/p>\n
\nLuxembourg<\/p>\n
\nSouth Korea<\/p>\n
\nConsciencializa\u00e7\u00e3o p\u00fablica (projectos existentes)<\/h2>\n
\nUSA
\nTransforming Medical Research<\/p>\n
\nSpain
\nInvestigation at Vivotecnia laboratory<\/p>\n
\nGermany
\nLily Bowers and the Uninvited Guest<\/p>\n
\nUSA
\nSave Ralph<\/p>\n
\nSouth Korea
\nStopped animal testing on service dogs<\/p>\n
\nGermany
\nA systematic review on the conflicts between REACH and the EU Cosmetic Regulation: from awareness to action<\/p>\n
\nFrance
\nInvestigating about households products experiments<\/p>\n
\nConsciencializa\u00e7\u00e3o p\u00fablica (projetos futuros)<\/h2>\n
\nChile
\nBanning animal testing for cosmetics in Argentina<\/p>\n
\nBelgium
\nPlaying and coding for alternatives to animal testing<\/p>\n
\nBelgium
\nAnnual ‘Pure Evil’ award campaign<\/p>\n
\nEduca\u00e7\u00e3o<\/h2>\n
\nNetherlands
\nProefdiervrij Venture Challenge<\/p>\n
\nIndia
\nTraining and education in 1R approaches in India<\/p>\n
\nUK
\nSummer Student Programme: Next Generation<\/p>\n
\nMexico
\n3D Tissues: An alternative to animal testing<\/p>\n
\nGermany
\nReplacing Fetal Bovine Serum (FBS) in Research & Testing<\/p>\n
\nItaly
\nIntroducing the Three Rs in education programmes and curricula<\/p>\n
\nNetherlands
\nESTIV Applied Training Course<\/p>\n
\nGermany
\nNAT-Database: Raising public awareness for Non-Animal Technologies to promote a human-based research generating human-relevant results<\/p>\n
\nBosnia and Herzegovina
\nDual Education System As a New Tool for Improving Practical Skills and Vocational Training of Veterinary Students<\/p>\n
\nCi\u00eancia<\/h2>\n
\nGermany
\nIn silico toxicology platform based on endocrine organ-on-a-chip systems<\/p>\n
\nSwitzerland
\nBuilding a strategy to assess the neurotoxicity of solvents<\/p>\n
\nUSA
\nKnowledge-guided deep learning models of drug toxicity improve prediction and interpretation<\/p>\n
\nGermany
\nDemonstrating metabolism of a hair dye in the skin and liver in co-culture<\/p>\n
\nPortugal
\nA Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators<\/p>\n
\nSouth Korea
\nDevelopment of 3D tissue chip models mimicking multiple organs<\/p>\n
\nUSA
\nMapping mechanistic pathways of acute oral systemic toxicity using chemical structure and bioactivity measurements<\/p>\n
\nSwitzerland
\nA barrier-on-chip with integrated 3D stretching: an alternative predictive tool to support decision making<\/p>\n
\nUK
\nOrgan-on-a-Chip for better model of human physiology<\/p>\n
\nUSA
\nAddressing the acceptance of in silico toxicology<\/p>\n
\nAustralia
\nOrgans-on-chips (OoCs) for modelling drug responses mediated by multi-cellular interactions<\/p>\n
\nGermany
\nSystems engineering of microphysiometry<\/p>\n
\nItaly
\nUse of human cell-based assays anchored to mechanistically relevant key events as a tool for the regulatory testing of developmental neurotoxicity<\/p>\n
\nFrance
\nEfforts towards international harmonization of NAMs<\/p>\n
\nChina
\nDevelop Automatic Organs-on-Chip Systems<\/p>\n
\nNetherlands
\nReproTracker: an in vitro alternative to animal models for developmental toxicity testing<\/p>\n
\nNetherlands
\nNew approach methods (NAMs) supporting read-across: Two neurotoxicity AOP-based IATA case studies.<\/p>\n
\nJovem Investigador\/a<\/h2>\n
\nUSA
\nIn Silico modeling of Mixtures toxicity of hazardous Chemicals through multitude approaches<\/p>\n
\nUSA
\nDevelopment of Mechanism-driven Virtual Adverse Outcome Pathway (vAOP) for Hepatotoxicity<\/p>\n
\nNetherlands
\nCombining artificial intelligence and human organoids for animal-free drug discovery: towards a paradigm shift<\/p>\n
\nAustria
\nWe make human placenta great again and an animal-free pepsin!<\/p>\n
\nUK
\nBioelectronic technology and Organs-on-Chips synergy: A 3D in vitro platform sheds light in the human microbiome-gut-brain axis interactions<\/p>\n
\nBrazil
\nLung-sens-on-a-chip model for mechanistic assessment of chemically-induced pulmonary sensitization: Providing building blocks for the respiratory allergy AOP<\/p>\n
\nItaly
\nImprovement of an innovative 3D human-based model useful to identify the key events behind glaucoma pathogenesis<\/p>\n
\nNetherlands
\nA joint-on-chip model to tackle arthritis<\/p>\n
\nIran
\nUsing the microfluidic device for inducing oxidative stress on endothelial cells and assessing of antioxidant activity of gold nanoparticles attached to polyphenols<\/p>\n
\nGermany
\nAdvancing a human stem cell-derived test system for neurotoxicity<\/p>\n
\nUK
\nDevelopment of healthy and immunocompromised dynamic lung co-culture models for toxicity testing<\/p>\n
\nGermany
\nIdentification of serum-free cell culture media formulations with automated and standardized microphysiometry<\/p>\n
\nGermany
\nUse of a dynamic 3-organ co-culture in the HUMIMIC Chip3 to assess endocrine disrupting properties of test compounds<\/p>\n
\nUSA
\nInhalation toxicology\u2010on\u2010a\u2010chip<\/p>\n
\nSwitzerland
\nSmoking alveolosphere on-chip to study COPD and lung cancer exacerbations<\/p>\n
\nUK
\nIntegrating physiologically-based pharmacokinetic modelling and \u2018omics data to derive health-based guidance values for perfluorinated chemicals<\/p>\n
\nUK
\nA robotic process automation system for biomanufacturing animal-free in-vitro 3D tissue and organoid models for drug screening<\/p>\n
\nUSA
\nComputational Cardiotoxicology: Building an AI-assisted alternative method-based toxicity screening pipeline<\/p>\n
\nUK
\nUsing patient derived cells to build brain blood vessels in a chip: developing a new model to study cerebral small vessel disease and stroke<\/p>\n